Dr.Beom-JunKim South Korea

Dr.Beom-JunKim
Dr. Beom-Jun Kim is a tenured Professor in the Division of Endocrinology and Metabolism at Asan Medical Center, University of Ulsan College of Medicine, South Korea, where he also completed his M.D., Ph.D., and clinical training. His research integrates basic, translational, and clinical approaches to address musculoskeletal health and the biology of aging. While his early work focused on osteoporosis, his current interests have expanded to sarcopenia and frailty, with a particular emphasis on discovering blood-based biomarkers and novel therapeutic targets for healthy aging. Dr. Kim holds numerous patents and has published extensively in international journals.

22 MARCH

Time Session
11:00
12:30
ESROC-KES Joint Symposium
Updates in Endocrinology: Emerging Insights into Adrenal Disorders, Muscle Health, and Endocrine Diseases
  • Pheochromocytoma: Current Concepts and Emerging Evidence
    Min Jeong ParkSouth Korea Speaker Pheochromocytoma: Current Concepts and Emerging Evidence
  • Translational Research for Developing Blood-Based Biomarkers of Sarcopenia
    Beom-Jun KimSouth Korea Speaker Translational Research for Developing Blood-Based Biomarkers of Sarcopenia
  • Anxiety in Patients with Thyroid Nodules: What Clinicians Need to Know
    Edy KorneliusTaiwan Speaker Anxiety in Patients with Thyroid Nodules: What Clinicians Need to KnowThyroid nodules are commonly encountered in endocrine practice, and while the majority are benign, the diagnostic and surveillance process often imposes a substantial psychological burden on patients. Anxiety related to fear of malignancy, uncertainty surrounding ultrasonographic findings, fine-needle aspiration results, and long-term follow-up is frequently underestimated and insufficiently addressed in routine clinical care. Emerging evidence suggests that anxiety in patients with thyroid nodules may persist even after reassurance of benign disease and can significantly affect quality of life, healthcare utilization, and decision-making preferences. Cancer-related worry is often disproportionate to the actual risk of malignancy and may be exacerbated by repeated imaging, indeterminate cytology, ambiguous terminology, and lack of clear follow-up strategies. Heightened anxiety has been associated with increased demand for diagnostic interventions and preference for aggressive management, potentially leading to overtreatment. This presentation reviews current evidence on the prevalence, determinants, and clinical consequences of anxiety among patients with thyroid nodules, integrating published literature with real-world clinical experience. Practical approaches for identifying psychological distress in outpatient settings and strategies for improving communication and expectation management will be discussed. Recognizing and addressing anxiety as an integral component of thyroid nodule care is essential for delivering holistic, patient-centred, and value-based endocrinology.
  • Impaired Fasting Glucose and Musculoskeletal Disorders
    Yi-Sun YangTaiwan Speaker Impaired Fasting Glucose and Musculoskeletal Disorders
  • Discussion
103